Header Logo

Connection

SANJAY MATHEW to Piperidines

Back to Details
This is a "connection" page, showing publications SANJAY MATHEW has written about Piperidines.
SANJAY MATHEW
Connection Strength
0.326
Piperidines
  1. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur Neuropsychopharmacol. 2011 Mar; 21(3):221-9.
    View in: PubMed
    Score: 0.326
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.